Objective Dravet Syndrome (DS) is a catastrophic form of paediatric epilepsy associated with multiple comorbidities mainly caused by mutations in the SCN1A gene. DS progresses in three different phases termed febrile, worsening and stabilization stage. Mice that are haploinsufficient for Scn1a faithfully model each stage of DS, although various aspects have not been fully described, including the temporal appearance and sex differences of the epilepsy and comorbidities. The aim of the present study was to investigate the epilepsy landscape according to the progression of DS and the long-term co-morbidities in the Scn1a(+/-)tm1Kea DS mouse line that are not fully understood yet. Methods Male and female F1.Scn1a(+/+) and F1.Scn1a(+/-)tm1Kea m...
International audienceSCN1A (NaV1.1 sodium channel) mutations cause Dravet syndrome (DS) and GEFS+ (...
International audienceSCN1A (NaV1.1 sodium channel) mutations cause Dravet syndrome (DS) and GEFS+ (...
Dravet syndrome (DS) is a debilitating infantile epileptic encephalopathy characterized by seizures ...
Objective Dravet Syndrome (DS) is a catastrophic form of paediatric epilepsy associated with multipl...
Objective: Dravet Syndrome (DS) is a catastrophic form of paediatric epilepsy associated with multip...
Objective: Dravet Syndrome (DS) is a catastrophic form of paediatric epilepsy associated with multip...
Dravet Syndrome (DS) is an encephalopathy with epilepsy associated with multiple neuropsychiatric co...
Dravet Syndrome (DS) is an encephalopathy with epilepsy associated with multiple neuropsychiatric co...
Dravet Syndrome (DS) is an encephalopathy with epilepsy associated with multiple neuropsychiatric co...
Les mutations du gène SCN1A, sont impliquées dans des épilepsies du nourrisson : le Syndrome de Drav...
International audienceSCN1A (NaV1.1 sodium channel) mutations cause Dravet syndrome (DS) and GEFS+ (...
International audienceSCN1A (NaV1.1 sodium channel) mutations cause Dravet syndrome (DS) and GEFS+ (...
International audienceSCN1A (NaV1.1 sodium channel) mutations cause Dravet syndrome (DS) and GEFS+ (...
International audienceSCN1A (NaV1.1 sodium channel) mutations cause Dravet syndrome (DS) and GEFS+ (...
International audienceSCN1A (NaV1.1 sodium channel) mutations cause Dravet syndrome (DS) and GEFS+ (...
International audienceSCN1A (NaV1.1 sodium channel) mutations cause Dravet syndrome (DS) and GEFS+ (...
International audienceSCN1A (NaV1.1 sodium channel) mutations cause Dravet syndrome (DS) and GEFS+ (...
Dravet syndrome (DS) is a debilitating infantile epileptic encephalopathy characterized by seizures ...
Objective Dravet Syndrome (DS) is a catastrophic form of paediatric epilepsy associated with multipl...
Objective: Dravet Syndrome (DS) is a catastrophic form of paediatric epilepsy associated with multip...
Objective: Dravet Syndrome (DS) is a catastrophic form of paediatric epilepsy associated with multip...
Dravet Syndrome (DS) is an encephalopathy with epilepsy associated with multiple neuropsychiatric co...
Dravet Syndrome (DS) is an encephalopathy with epilepsy associated with multiple neuropsychiatric co...
Dravet Syndrome (DS) is an encephalopathy with epilepsy associated with multiple neuropsychiatric co...
Les mutations du gène SCN1A, sont impliquées dans des épilepsies du nourrisson : le Syndrome de Drav...
International audienceSCN1A (NaV1.1 sodium channel) mutations cause Dravet syndrome (DS) and GEFS+ (...
International audienceSCN1A (NaV1.1 sodium channel) mutations cause Dravet syndrome (DS) and GEFS+ (...
International audienceSCN1A (NaV1.1 sodium channel) mutations cause Dravet syndrome (DS) and GEFS+ (...
International audienceSCN1A (NaV1.1 sodium channel) mutations cause Dravet syndrome (DS) and GEFS+ (...
International audienceSCN1A (NaV1.1 sodium channel) mutations cause Dravet syndrome (DS) and GEFS+ (...
International audienceSCN1A (NaV1.1 sodium channel) mutations cause Dravet syndrome (DS) and GEFS+ (...
International audienceSCN1A (NaV1.1 sodium channel) mutations cause Dravet syndrome (DS) and GEFS+ (...
Dravet syndrome (DS) is a debilitating infantile epileptic encephalopathy characterized by seizures ...